Title: Synthetic human monoclonal antibody targets hIL1 receptor accessory protein chain with therapeutic potential in triple-negative breast cancer

Journal Article · · Biomedicine and Pharmacotherapy
; ; ; ; ;

Not Available

Sponsoring Organization:
USDOE
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1778382
Journal Information:
Biomedicine and Pharmacotherapy, Journal Name: Biomedicine and Pharmacotherapy Journal Issue: C Vol. 107; ISSN 0753-3322
Publisher:
ElsevierCopyright Statement
Country of Publication:
France
Language:
English

References (28)

Zerumbone Suppresses IL-1β-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells: THE EFFECT OF ZERUMBONE ON IL-1β-INDUCED CELL MOTILITY journal May 2014
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study journal May 2014
Inhibiting NF-κB activation by small molecules as a therapeutic strategy journal October 2010
The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression journal August 2017
Overview of the interleukin-1 family of ligands and receptors journal December 2013
Beyond natural antibodies: the power of in vitro display technologies journal March 2011
Synthetic therapeutic antibodies journal December 2006
The structural basis for receptor recognition of human interleukin-18 journal December 2014
Structure of the activating IL-1 receptor signaling complex journal March 2012
IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells journal November 2007
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia journal August 2015
The Interleukin-1 Receptor Accessory Protein (IL-1RAcP) Is Essential for IL-1-induced Activation of Interleukin-1 Receptor-associated Kinase (IRAK) and Stress-activated Protein Kinases (SAP Kinases) journal March 1997
Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity journal September 2011
IL-1R–MyD88 signaling in keratinocyte transformation and carcinogenesis journal August 2012
Triple-negative breast cancer—current status and future directions journal December 2009
Construction and Expression of Bi-Functional Proteins of Single-Chain Fv With Effector Domains journal August 1996
Cleavage-site motifs in mitochondrial targeting peptides journal January 1990
IL-1 and IL-1 regulatory pathways in cancer progression and therapy journal December 2017
Single-chain antigen-binding proteins journal October 1988
IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation journal October 2015
Neocortical-Like Organization of Avian Auditory ‘Cortex’ journal January 2010
Hematopoietic growth factors and their receptors in acute leukemia journal January 1993
Development of an EGFRvIII specific recombinant antibody journal January 2010
Adiponectin and metformin additively attenuate IL1β-induced malignant potential of colon cancer journal September 2013
Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer journal March 2017
IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production journal August 2015
Deregulation of HER2 Downstream Signaling in Breast Cancer Cells by a Cocktail of Anti-HER2 scFvs journal July 2013
IL-1 Receptor Accessory Protein Is an Essential Component of the IL-1 Receptor journal November 1998

Similar Records

Related Subjects